Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Morphic
Morphic
Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in
Pharma Voice
Thu, 11/7/24 - 11:12 am
M&A
Vertex Pharmacuticals
Alpine Immune Sciences
Eli Lilly
Morphic
Novartis
MorphoSys
Mariana Oncology
AstraZeneca
Fusion Pharmaceuticals
Lundbeck
Longboard Pharmaceuticals
AbbVie
Aliada Therapeutics
Morphic kept it simple in M&A maneuvers, staying focused on Lilly to reel in $3.2B buyout
Fierce Biotech
Fri, 07/19/24 - 11:54 am
Morphic
Eli Lilly
M&A
Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster
Fierce Biotech
Mon, 07/8/24 - 11:54 am
Eli Lilly
Morphic
M&A
Takeda
Entyvio
IBD